scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/S0925-4439(99)00066-6 |
P698 | PubMed publication ID | 10571019 |
P2093 | author name string | Y Ihara | |
N Taniguchi | |||
Y Ikeda | |||
E Miyoshi | |||
J H Ko | |||
P2860 | cites work | Glycobiology | Q22255657 |
ETS1 suppresses tumorigenicity of human colon cancer cells | Q24318370 | ||
Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice | Q24321587 | ||
cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. | Q31117684 | ||
Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection | Q33924286 | ||
Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene | Q34433644 | ||
Ectopic expression of N-acetylglucosaminyltransferase III in transgenic hepatocytes disrupts apolipoprotein B secretion and induces aberrant cellular morphology with lipid storage | Q35925263 | ||
Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. | Q36382577 | ||
Characterization of the human CD4 gene promoter: transcription from the CD4 gene core promoter is tissue-specific and is activated by Ets proteins | Q36487614 | ||
Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene | Q36648885 | ||
A phorbol ester response element within the human T-cell receptor beta-chain enhancer | Q37258998 | ||
Transfection of N-acetylglucosaminyltransferase III gene suppresses expression of hepatitis B virus in a human hepatoma cell line, HB611. | Q38288964 | ||
Organization of the Human N‐Acetylglucosaminyltransferase V Gene | Q38290925 | ||
The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products | Q38331805 | ||
Sequence-specific binding of human Ets-1 to the T cell receptor alpha gene enhancer | Q38338362 | ||
Remodeling of glycoconjugates on CD44 enhances cell adhesion to hyaluronate, tumor growth and metastasis in B16 melanoma cells expressing beta1,4-N-acetylglucosaminyltransferase III. | Q38341433 | ||
Gene transfection-mediated overexpression of beta1,4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function | Q38346921 | ||
Bisecting GlcNAc structures act as negative sorting signals for cell surface glycoproteins in forskolin-treated rat hepatoma cells | Q38349148 | ||
Binding of erythroagglutinating phytohemagglutinin lectin from Phaseolus vulgaris to the epidermal growth factor receptor inhibits receptor function in the human glioma cell line, U373 MG. | Q38351233 | ||
Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. | Q38352116 | ||
Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides | Q39735775 | ||
The Ets family of transcription factors | Q40871575 | ||
Recent progress in the molecular biology of the cloned N-acetylglucosaminyltransferases | Q41071120 | ||
Remodeling of cell surface glycoproteins by N-acetylglucosaminyltransferase III gene transfection: modulation of metastatic potentials and down regulation of hepatitis B virus replication | Q41254495 | ||
Regulation of the human TNF promoter by the transcription factor Ets. | Q41358666 | ||
High expression of UDP-N-acetylglucosamine: beta-D mannoside beta-1,4-N-acetylglucosaminyltransferase III (GnT-III) in chronic myelogenous leukemia in blast crisis | Q41370639 | ||
Purification and characterization of UDP-N-acetylglucosamine: alpha-6-D-mannoside beta 1-6N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase V) from a human lung cancer cell line | Q41556000 | ||
Identification of a novel interleukin-6 response element containing an Ets-binding site and a CRE-like site in the junB promoter | Q41945472 | ||
Effects of epidermal growth factor and insulin on the activity of N-acetylglucosaminyltransferase V | Q42036929 | ||
Transfection by human oncogenes: concomitant induction of tumorigenicity and tumor-associated membrane alterations | Q42816377 | ||
Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction | Q48054382 | ||
The Ets transcription factors encoded by the Drosophila gene pointed direct glial cell differentiation in the embryonic CNS. | Q52542347 | ||
Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. | Q53529803 | ||
The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts | Q67915677 | ||
High expression of an N-acetylglucosaminyltransferase III in 3'-methyl DAB-induced hepatoma and ascites hepatoma | Q70076912 | ||
Solution conformation of asparagine-linked oligosaccharides: alpha(1-6)-linked moiety | Q71027325 | ||
Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis | Q71143181 | ||
Transforming growth factor beta up-regulates expression of the N-acetylglucosaminyltransferase V gene in mouse melanoma cells | Q72631642 | ||
Overexpression of N-acetylglucosaminyltransferase III disrupts the tyrosine phosphorylation of Trk with resultant signaling dysfunction in PC12 cells treated with nerve growth factor | Q73201739 | ||
Elevated activity of N-acetylglucosaminyltransferase V in human hepatocellular carcinoma | Q74303893 | ||
Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines | Q78101630 | ||
P433 | issue | 2-3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 287-300 | |
P577 | publication date | 1999-10-01 | |
P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
P1476 | title | Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism | |
P478 | volume | 1455 |
Q38763337 | A glycoproteomic approach to identify novel glycomarkers for cancer stem cells |
Q51088233 | A novel pathogenesis of inflammatory bowel disease from the perspective of glyco-immunology. |
Q37618865 | Aberrant glycosylation as biomarker for cancer: focus on CD43. |
Q40145507 | Alpha1,3 Fucosyltransferase-VII modifies the susceptibility of apoptosis induced by ultraviolet and retinoic acid in human hepatocarcinoma cells |
Q44967506 | Alteration in N -acetylglucosaminyltransferase activities and glycan structure in tissue and bile glycoproteins from extrahepatic bile duct carcinoma |
Q92510332 | Astrocytes Modify Migration of PBMCs Induced by β-Amyloid in a Blood-Brain Barrier in vitro Model |
Q39456745 | Cadherins Glycans in Cancer: Sweet Players in a Bitter Process. |
Q38285397 | Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense |
Q38348733 | Carbohydrate Binding Activity of Annexin V toward a Bisecting N-Acetylglucosamine |
Q34970766 | Cell surface glycan alterations in epithelial mesenchymal transition process of Huh7 hepatocellular carcinoma cell |
Q39870315 | Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells. |
Q90066183 | Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells |
Q84979105 | Differential glycan profiling by lectin microarray targeting tissue specimens |
Q40330255 | Down regulation of N-acetylglucosaminyltransferase V facilitates all-transretinoic acid to induce apoptosis of human hepatocarcinoma cells |
Q34158632 | Down-regulation of hydrogen peroxide-induced PKC delta activation in N-acetylglucosaminyltransferase III-transfected HeLaS3 cells. |
Q34308676 | Effect of N-acetylglucosaminyltransferase V on the expressions of other glycosyltransferases. |
Q24313363 | Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling |
Q30418119 | Evolutional and clinical implications of the epigenetic regulation of protein glycosylation. |
Q39165964 | Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder |
Q34451930 | Function characterization of a glyco-engineered anti-EGFR monoclonal antibody cetuximab in vitro |
Q39188642 | Functional roles of glycogene and N-glycan in multidrug resistance of human breast cancer cells |
Q40352493 | Glycomic/glycoproteomic analysis by liquid chromatography/mass spectrometry: analysis of glycan structural alteration in cells |
Q36742398 | Glycoprotein disease markers and single protein-omics |
Q33764483 | Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis |
Q30943640 | Glycosyltransferase expression in human colonic tissue examined by oligonucleotide arrays |
Q35175978 | GnT-V, macrophage and cancer metastasis: a common link |
Q38290308 | Hepatic aberrant glycosylation by N-acetylglucosaminyltransferase V accelerates HDL assembly |
Q44448443 | Heterogeneity in gamma-glutamyltransferase mRNA expression and glycan structures. Search for tumor-specific variants in human liver metastases and colon carcinoma cells. |
Q36259885 | Hexosamine-Induced TGF-β Signaling and Osteogenic Differentiation of Dental Pulp Stem Cells Are Dependent on N-Acetylglucosaminyltransferase V. |
Q33393905 | Immune defects in Alzheimer's disease: new medications development |
Q33764477 | Immunoglobulins are the major glycoproteins involved in the modifications of total serum N-glycome in cirrhotic patients. |
Q24682639 | Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin |
Q37989564 | Integrated approach toward the discovery of glyco-biomarkers of inflammation-related diseases |
Q40166293 | Introduction of bisecting GlcNAc in N-glycans of adenylyl cyclase III enhances its activity. |
Q37774870 | Involvement of aberrant glycosylation in thyroid cancer |
Q37461699 | Lentiviral vector-mediated shRNA against AIMP2-DX2 suppresses lung cancer cell growth through blocking glucose uptake |
Q39225654 | Lewis y antigen is expressed in oral squamous cell carcinoma cell lines and tissues, but disappears in the invasive regions leading to the enhanced malignant properties irrespective of sialyl-Lewis x. |
Q34200620 | Loss and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions |
Q42700864 | Loss of Barx1 promotes hepatocellular carcinoma metastasis through up-regulating MGAT5 and MMP9 expression and indicates poor prognosis |
Q31145803 | Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma |
Q39272991 | Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation |
Q37812004 | Modulation of E-cadherin function and dysfunction by N-glycosylation. |
Q58761454 | Multiple Roles of Glycans in Hematological Malignancies |
Q53352972 | N-Acetylglucosaminyltransferase V exacerbates murine colitis with macrophage dysfunction and enhances colitic tumorigenesis. |
Q53274966 | N-Acetylglucosaminyltransferase V regulates TGF-β response in hepatic stellate cells and the progression of steatohepatitis. |
Q80880709 | N-acetylglucosaminyltransferase V modifies TrKA protein, regulates the receptor function |
Q38842197 | N-acetylglucosaminyltransferase V modulates radiosensitivity and migration of small cell lung cancer through epithelial-mesenchymal transition |
Q37392746 | Negative expression of N-acetylglucosaminyltransferase V in oral squamous cell carcinoma correlates with poor prognosis. |
Q47281580 | Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology? |
Q36294695 | Overexpression and β-1,6-N-acetylglucosaminylation-initiated aberrant glycosylation of TIMP-1: a "double whammy" strategy in colon cancer progression |
Q43514108 | Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors. |
Q89885926 | Partial silencing of fucosyltransferase 8 gene expression inhibits proliferation of Ishikawa cells, a cell line of endometrial cancer |
Q36667067 | Phenotype changes of Fut8 knockout mouse: core fucosylation is crucial for the function of growth factor receptor(s). |
Q32031755 | Rapid analysis of amino sugars by microchip electrophoresis with laser-induced fluorescence detection |
Q48425028 | Region-specific and epileptogenic-dependent expression of six subtypes of alpha2,3-sialyltransferase in the adult mouse brain |
Q28366050 | Regulation of differentiation- and proliferation-inducers on Lewis antigens, alpha-fucosyltransferase and metastatic potential in hepatocarcinoma cells |
Q40461099 | Regulation of metastasis-suppressive gene Nm23-H1 on glycosyl-transferases involved in the synthesis of sialyl Lewis antigens. |
Q40629726 | Regulation on the expression and N-glycosylation of integrins by N-acetylglucosaminyltransferase V |
Q40540137 | Relations of the type and branch of surface N-glycans to cell adhesion, migration and integrin expressions |
Q45869399 | Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells. |
Q34555935 | Reversibility of membrane N-glycome of HeLa cells upon treatment with epigenetic inhibitors |
Q55401338 | Serum profile of transferrin isoforms in juvenile idiopathic arthritis: a preliminary study. |
Q34285184 | Suppression of beta 1,3galactosyltransferase beta 3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly N-acetyllactosamines and sialyl-Lewis x on O-glycans |
Q73054394 | The critical role of the stem region as a functional domain responsible for the oligomerization and Golgi localization of N-acetylglucosaminyltransferase V. The involvement of a domain homophilic interaction |
Q28742329 | The recognition of N-glycans by the lectin ArtinM mediates cell death of a human myeloid leukemia cell line |
Q34446989 | Wisteria floribunda agglutinin-binding glycan expression is decreased in endometriomata |
Search more.